Cyfuse Biomedical Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
26
- Stock Symbol
-
4892
- Share Price
-
$3.16
- (As of Thursday Closing)
Cyfuse Biomedical General Information
Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine-related products. The company focuses on delivering three-dimensional tissues and organs created solely from cells as new 3D cell products to medical fields, including regenerative medicine and drug discovery, through the practical application of three-dimensional cell stacking technology. It is engaged in multifaceted development in the following areas: regenerative medicine, drug discovery support, and the device domain, including the development and sales of 3D cell stacking system equipment, such as bio 3D printers equipped with the company's platform technology.
Contact Information
Website
www.cyfusebio.comCorporate Office
- South Tower, Sumitomo Fudosan Tokyo Mita
- 3-5-27 Mita, Minato-ku
- Tokyo, 108-6301
- Japan
Corporate Office
- South Tower, Sumitomo Fudosan Tokyo Mita
- 3-5-27 Mita, Minato-ku
- Tokyo, 108-6301
- Japan
Cyfuse Biomedical Stock Performance
As of 19-Nov-2026, Cyfuse Biomedical’s stock price is $3.16. Its current market cap is $31.8M with 10.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.16 | $3.23 | $2.98 - $4.79 | $31.8M | 10.1M | 52.8K | -$0.53 |
Cyfuse Biomedical Financials Summary
As of 30-Jun-2026, Cyfuse Biomedical has a trailing 12-month revenue of $1.98M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,688 | 17,581 | 6,927 | 20,745 |
| Revenue | 1,981 | 1,543 | 360 | 435 |
| EBITDA | (4,843) | (4,779) | (5,445) | (3,831) |
| Net Income | (5,154) | (5,104) | (5,759) | (4,193) |
| Total Assets | 24,244 | 27,272 | 22,403 | 29,886 |
| Total Debt | 7,614 | 8,387 | 5,431 | 6,474 |
Cyfuse Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyfuse Biomedical Comparisons
Industry
Financing
Details
Cyfuse Biomedical Competitors (15)
One of Cyfuse Biomedical’s 15 competitors is 3D Biotek, a Corporate Backed or Acquired company based in Bridgewater, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 3D Biotek | Corporate Backed or Acquired | Bridgewater, NJ | ||||
| Fluicell | Formerly VC-backed | Molndal, Sweden | ||||
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| Histogen | Formerly VC-backed | San Ramon, CA | ||||
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX |
Cyfuse Biomedical Patents
Cyfuse Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026197045-A1 | Method for evaluating periodontal tissue regeneration ability of cell structure for transplantation | Pending | 19-Mar-2025 | ||
| WO-2026127150-A1 | Liver-like or liver tissue-like structure | Pending | 09-Dec-2024 | ||
| JP-2025140768-A | Cryopreservation method for tublar cell structure, cryopreservation tool and frozen substance | Pending | 14-Mar-2024 | ||
| JP-2024156287-A | Angle adjustment mechanism and puncture device | Pending | 24-Apr-2023 | ||
| JP-2024151045-A | Dispensing device | Pending | 11-Apr-2023 |
Cyfuse Biomedical Signals
Cyfuse Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cyfuse Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Cyfuse Biomedical FAQs
-
When was Cyfuse Biomedical founded?
Cyfuse Biomedical was founded in 2010.
-
Where is Cyfuse Biomedical headquartered?
Cyfuse Biomedical is headquartered in Tokyo, Japan.
-
What is the size of Cyfuse Biomedical?
Cyfuse Biomedical has 26 total employees.
-
What industry is Cyfuse Biomedical in?
Cyfuse Biomedical’s primary industry is Biotechnology.
-
Is Cyfuse Biomedical a private or public company?
Cyfuse Biomedical is a Public company.
-
What is Cyfuse Biomedical’s stock symbol?
The ticker symbol for Cyfuse Biomedical is 4892.
-
What is the current stock price of Cyfuse Biomedical?
As of 19-Nov-2026 the stock price of Cyfuse Biomedical is $3.16.
-
What is the current market cap of Cyfuse Biomedical?
The current market capitalization of Cyfuse Biomedical is $31.8M.
-
What is Cyfuse Biomedical’s current revenue?
The trailing twelve month revenue for Cyfuse Biomedical is $1.98M.
-
Who are Cyfuse Biomedical’s competitors?
3D Biotek, Fluicell, Aspect Biosystems, Histogen, and Synthecon are some of the 15 competitors of Cyfuse Biomedical.
-
What is Cyfuse Biomedical’s annual earnings per share (EPS)?
Cyfuse Biomedical’s EPS for 12 months was -$0.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process